Page 29 - வெள்ளை வீடு அலுவலகம் ஆஃப் தேசிய மருந்து கட்டுப்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Posted on April 30, 2021 by dmartignetti LD 675  (Sponsored By Troy Jackson) An Act To Protect Maine Consumers from Unsupported Price Increases on Prescription Medicines by Creating an Independent Review Process. Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America

United statesCapitol hillWilliams smithJohn baldacciMatt gagnonPfizer inc as viceCatholic university of americaSession of congressWhite house office of national drug controlNational politicsPublic affairsLife sciencesWilliam smithSponsored by troy jacksonUnsupported price increasesPrescription medicines